Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

• by Vincent Levy, Mario Jreige, Laura Haefliger, Celine Du Pasquier, Camille Noirot, Anna Dorothea Wagner, Styliani Mantziari, Markus Schäfer, Naik Vietti-Violi, Clarisse Dromain

• May 16, 2025

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.

• by Andrea Surnit

• May 6, 2026

• 4 min

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches

• by Andrea Surnit

• May 1, 2026

• 5 min

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies

• by Hu Chen, Shuai Li, Qiuyu Yang, Fangzheng Zhou

• April 23, 2026